UPDATED 12.06.2014 09:58

Organised cervical cancer screening programme in the Tampere region in Finland in the invitation year 2012. Numbers and percentage distribution of primary screening test results, referrals for further examinations, and histological diagnosis of the cervix uteri.

Screening Screened Referral Histological diagnosis
test     Invasive
carcinoma
Microinvasive
carcinoma
Carcinoma
in situ
Dysplasia
gravis
Dysplasia
moderata
Dysplasia
levis
Other or
normal
  n n % n % n % n % n % n % n % n %
Pap test1 35178 255 0.72 2 0.01 - - 3 0.01 49 0.14 29 0.08 28 0.08 144 0.41
I 33640 1 - - - - - - - - - - - - - 1 -
II 1285 14 0.04 - - - - - - - - - - 2 0.01 12 0.03
III 210 204 0.58 2 0.01 - - - - 38 0.11 25 0.07 22 0.06 117 0.33
IV 34 34 0.10 - - - - 3 0.01 11 0.03 3 0.01 4 0.01 13 0.04
V 2 2 0.01 - - - - - - - - 1 - - - 1 -
Inadequate 6 - - - - - - - - - - - - - - - -
Unknown 1 - - - - - - - - - - - - - - - -
HPV test 5630 52 0.92 1 0.02 - - 1 0.02 10 0.18 3 0.05 3 0.05 34 0.60
Negative1 5280 2 0.04 - - - - - - - - - - - - 2 0.04
Positive2 350 50 0.89 1 0.02 - - 1 0.02 10 0.18 3 0.05 3 0.05 32 0.57
Total 40808 307 0.75 3 0.01 - - 4 0.01 59 0.14 32 0.08 31 0.08 178 0.44

1 Women with Papanicolaou class I or II negative HPV test are not referred for further examinations unless repeated cytology or other results are suggestive of cancer.
2 Women whose HPV test is positive are referred for further examinations on the basis of cytology or a repeatedly positive result.